NTRK1 and sarcoma: Gene expression profiling has identified high levels of tyrosine kinase and receptor tyrosine kinase expression in a number of sarcoma types, indicating that sarcomas may potentially be candidates for therapy with tyrosine kinase inhibitors [7-14].